In metastatic melanoma, NKp30 ligands were minimally expressed [25], while NKp44 and NKp46 ligands had heterogenous expression that seemed to depend on tumor heterogeneity and site of disease [25,26]. This evidence concerns the gene NCR2 and neoplasm.